Asthma and COVID-19: a systematic review
Abstract Background Severe coronavirus disease-19 (COVID-19) presents with progressive dyspnea, which results from acute lung inflammatory edema leading to hypoxia. As with other infectious diseases that affect the respiratory tract, asthma has been cited as a potential risk factor for severe COVID-...
Main Authors: | Natália F. Mendes, Carlos P. Jara, Eli Mansour, Eliana P. Araújo, Licio A. Velloso |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13223-020-00509-y |
Similar Items
-
Prevalence and Risk Factors of COVID-19 Symptoms among U.S. Adults with Allergies
by: Marlene Camacho-Rivera, et al.
Published: (2021-02-01) -
Lack of association between vitamin D insufficiency and clinical outcomes of patients with COVID-19 infection
by: Alireza Davoudi, et al.
Published: (2021-05-01) -
COVID-19–Related Misinformation among Parents of Patients with Pediatric Cancer
by: Jeanine P.D. Guidry, et al.
Published: (2021-02-01) -
Interpreting Transmissibility of COVID-19 in Children
by: Eun Young Cho, et al.
Published: (2020-12-01) -
KG-COVID-19: A Framework to Produce Customized Knowledge Graphs for COVID-19 Response
by: Justin T. Reese, et al.
Published: (2021-01-01)